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Table. EVAR results by decade
Variable
Age group, years
60-69 70-79 80-89 90
Patients, No. 33,629 56,783 32,493 1964
Mortality, % 0.46 .70 1.56 2.49
Average length of
stay, days 2.7 3.1 3.6 4.6
Average hospital
cost, $ 26,399 27,350 28,490 30,741
Discharge to SNF,
% 2.19 5.21 11.12 22.29
SNF, Skilled nursing facility.
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Objective(s): Although chronic obstructive pulmonary disease
(COPD) has been implicated as a risk factor for aneurysm rupture, its
impact on surgical repair remains undefined. Consequently, variation in
practice persists regarding patient selection and surgical management.
The purpose of this study was to analyze the effect of oxygen-dependent
COPD on patients undergoing abdominal aortic aneurysm (AAA) repair.
Methods: We reviewed a prospective regional registry of 3455
patients undergoing elective open and endovascular AAA repair from 23
centers in New England from 2003 to 2011. COPD was categorized as
none, mild (non-O2 dependent), and severe (O2 dependent). End points
included in-hospital death, pulmonary complications, major postopera-
tive adverse events (MAEs), extubation in the operating room, and
5-year survival. Survival was determined using life-table analysis. Predic-
tors of in-hospital and long-term mortality were determined by multivar-
iate logistic regression and Cox proportional hazards analysis.
Results: During the study interval, 2043 patients underwent EVAR
and 1412 underwent open AAA (oAAA) with a nearly equal prevalence of
COPD (35% EVAR vs 36% oAAA). Severe COPD was associated with
significantly increased in-hospital death, pulmonary complications, and
MAE (Fig) and with significantly decreased operating room extubation
among patients undergoing EVAR and oAAA. Five-year survival was
significantly diminished among all COPD patients (none, 78%; mild,
72%; severe, 42%; P  .001) undergoing AAA repair. By multivariate
analysis, O2-dependent COPD was independently associated with in-
hospital death (odds ratio, 2.02; 95% confidence interval, 1.0-4.0; P 
.04) and diminished 5-year survival (hazard ratio, 3.02; 95% confidence
interval, 2.2-4.1; P  .001).
Conclusions: Severe COPD is associated with increased pulmonary
complications, overall MAE, and diminished long-term survival among
patients undergoing AAA repair. Accordingly, aneurysm repair in patients
with COPD warrants extremely prudent risk/benefit assessment in the
setting of increased rupture risk but decreased 5-year survival.
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Objective(s): Type II endoleaks with growing aneurysm sac 5 mm
after endovascular aneurysm repair require treatment. Different treatment
options have been reported. This study evaluated the use of an ethylene-vinyl
alcohol copolymer (Onyx) in an endovascular approach, hereby presenting
our midterm results in 10 patients with 13 type II endoleaks.
Methods: Between January 2010 and December 2011, 10 patients
with 13 persistent type II endoleaks leading to aneurysm growth 5 mm
were treated in our center using transarterial Onyx embolization by super-
selective cannulation of the endoleak with microcatheters. Technical success
was defined as transarterial Onyx deployment directly into the aneurysm sac.
Clinical success was defined as stable or shrinking axial aneurysmal diameter
during follow-up using computed tomography angiography.
Results: Technical success was achieved in 12 of 13 (92%) type II
endoleaks. Two patients underwent a staged procedure because of several
unconnected type II endoleaks. In one patient, a cannulation of the en-
doleak was not possible. Continued efforts lead to a rupture of the hypogas-
tric artery, which was treated by covered stent implantation. In one patient,
an extravasation of Onyx out of the aneurysm sack into the inferior vena cava
during the embolization process made a transvenous goosesnare maneuver
necessary to retrieve the dislocated copolymer. Yet, no further complications
were observed because the endoleak was occluded. In all patients with
successful embolization, the aneurysm sac remained stable or shrank within
a mean follow-up of 19.8 months (range, 3-31 months).
Conclusions:The use of Onyx in the endovascular treatment of type II
endoleaks after endovascular aneurysm repair is feasible. Although this field
has scarce published data, transarterial copolymer embolization seems to
have a higher success rate than direct puncture. Further studies are necessary
to evaluate the value of these different treatment modalities.
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Objective(s):Acutemesenteric ischemia (AMI) is a commonly fatal result of
inadequate bowel perfusion that requires immediate evaluation by vascular and
general surgeons.Treatmentoften involves vascular repair aswell as bowel resection
andpossible need for total parenteral nutrition (TPN). Fewdata exist regarding the
rates of bowel resection after endovascular vs open repair of AMI.
Methods: The Nationwide Inpatient Sample database was used to
identify admissions from 2005 to 2009 according to International Classifi-
cation of Diseases, 9th Clinical Modification codes correlating to AMI
(557.0) and a subsequent vascular intervention (39.26, 38.16, 38.06, 39.9,
99.10). Patient-level data and the need for bowel resection (45.6, 45.71-9,
45.8) or TPN (99.10) during same hospitalization were examined.
Results: From 2005 to 2009, 23,744 patients presented with AMI, and
4,665 patients (66.5% women; mean age, 67.6 years) underwent interventional
treatment. The proportion of treated patients undergoing vascular intervention
increased from11.4%in2005to19.0%in2009(P .001).Amongpatients treated
with vascular intervention, 514 (75.7%) underwent open surgery and 165 (24.3%)
underwent endovascular treatment. Severity of comorbidities, as measured by the
Charlson index, did not differ significantly between the treatment groups. During
the study period, 12.2% undergoing endovascular procedures required bowel
resection comparedwith 29.8% for open revascularization (P .001). Inweighted
averages, patients undergoing endovascular repair also required TPN less often
(16.7% vs 24.1%; P .049).
Conclusions: Among AMI patients undergoing revascularization, en-
dovascular treatment was associated with decreased rate of bowel resection
(12.2%) and need for TPN (16.7%). Further research is warranted to
determine if increased use of endovascular repair could improve gastrointes-
tinal outcomes among patients requiring vascular repair for AMI.
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